Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged throughout the world. Building knowledge around Covid‐19 is crucial to devise facts based approaches to respond efficiently against this pandemic. AIM: We aimed to investigate pre‐existing humoral cross‐reactive imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Mveang Nzoghe, Amandine, Essone, Paulin N., Leboueny, Marielle, Maloupazoa Siawaya, Anicet Christel, Bongho, Eliode Cyrien, Mvoundza Ndjindji, Ofilia, Avome Houechenou, Rotimi Myrabelle, Agnandji, Selidji Todagbe, Djoba Siawaya, Joel Fleury
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860591/
https://www.ncbi.nlm.nih.gov/pubmed/33320447
http://dx.doi.org/10.1002/iid3.367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860591/
https://www.ncbi.nlm.nih.gov/pubmed/33320447
http://dx.doi.org/10.1002/iid3.367

Ejemplares similares